Success Stories: Successful I-140 NIW Approval Achieved for Researcher in the Field of Pharmaceutical Science with Our Dedicated Support

Client’s Testimonial:

“Thank you very much for your support throughout this process! It was truly a pleasure working with your team.”

On March 24^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Researcher in the Field of Pharmaceutical Science (Approval Notice).

General Field: Pharmaceutical Science

Position at the Time of Case Filing: Researcher

Country of Origin: South Korea

State of Residence at the Time of Filing: South Korea

Approval Notice Date: March 24^th, 2025

Processing Time: 1 month, 24 days (Premium Processing Requested)

Case Summary:

“By leveraging [Client’s] informative insights into oriental foliage, the United States is able to retain its standing as a leader in pharmaceutical research while also reducing the global burden of cancer.”

The excerpt above is drawn from one of two recommendation letters submitted in support of our client’s I-140 National Interest Waiver (NIW) petition. She is a researcher from South Korea with a Master’s degree in pharmacy. Leveraging our extensive experience, we employed a strategic, individualized approach to develop a persuasive, documented petition tailored to her strengths.

As an expert in the field of pharmaceutical science, our client’s proposed endeavor is to continue her research on integrating advanced technologies from interdisciplinary domains and utilizing computational approaches to develop novel drug candidates and improve drug delivery systems to create more effective, affordable, and stable pharmaceutical or biopharmaceutical medications for chronic diseases such as cancer, diabetes, hypertension, and neurodegenerative diseases.

Her proposed endeavor holds significant merit and serves the national interest by addressing urgent public health challenges while enhancing the overall management of chronic diseases in the United States. The potential impact of her work includes improving patient outcomes, elevating the quality of life, and reinforcing the resilience of the U.S. healthcare system.

To further support her case, we emphasized her strong academic and professional credentials:

She has authored 12 peer-reviewed journal articles (5 of them first- or co-first-authored), 10 conference abstracts (3 of them first-authored), 1 patent, and 2 patent application publications in no fewer than 8 highly ranked peer-reviewed journals.
Her works have been cited a total of 281 times, according to Google Scholar.
Her study has received funding from the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries and the National Research Foundation of Korea. This support of her research therefore further validates the importance and credibility of her work.

Given her advanced degree, proven record of success, and the clear alignment of her research with the NIW eligibility criteria, her petition was approved in just 1 month and 24 days through premium processing. We are proud to have played a role in her journey and look forward to her continued contributions to the field of pharmaceutical science.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.